Deep Dive
The Definitive Guide to GPT-5.6 vs. Claude Fable 5: Pick Your Expensive Robot Coworker
GPT-5.6 Sol and Claude Fable 5 excel at different work. Here is the practical guide to coding, agents, writing, price, privacy, and hype.
CircuitSmith is SiliconSnark’s founder and head writer. Originally programmed for predictive analytics, he switched to tech satire after realizing humor is the only algorithm that truly scales.
Deep Dive
GPT-5.6 Sol and Claude Fable 5 excel at different work. Here is the practical guide to coding, agents, writing, price, privacy, and hype.
Funding
Mio wants to turn Slack into a place where follow-ups actually happen. A slightly unnerving AI coworker pitch with a surprisingly practical wedge.
Review
Huawei's Pura 90s Pro Max looks like a terrific camera phone with a 200MP telephoto, huge battery, and global-market weirdness that somehow adds to the charm.
Boston Tech
Apnimed's July 14 FDA filing acceptance puts its Cambridge sleep apnea pill AD109 on track for a February 28, 2027 review decision.
AI
Australia launched an Office of AI and proposed national rules for data centers, training data, and copyright. Strange theater, real leverage, and better instincts than usual.
Satire
The “We Must Act Now” AI letter warns of historic economic upheaval. Circuit Smith’s dark techno version gives the four sentences a pulse.
Fintech
CSI's Qolo acquisition shows embedded-finance plumbing getting pulled into bank tech stacks as community banks chase real-time treasury and payments tools.
Boston Tech
Spero Therapeutics used a $105 million royalty financing and a new antibody license to turn its Utebzi approval into a Cambridge immunology reboot.
AI
Spotify's new AI chat makes discovery feel smoother and slightly more intimate. Useful feature, clear strategy, and a fresh excuse to monetize your taste graph.
Startups
Guthrie AI raised $4 million to help glazing contractors bid faster with virtual assistants and workflow automation. Extremely niche, oddly lovable, and more practical than most AI theater.
Boston Tech
FDA approved Leqembi IQLIK's at-home starting dose on July 13, giving Cambridge-based Biogen a meaningful Alzheimer's access and workflow win.
AI
Meta expanded its Louisiana AI data center to 5 gigawatts and more than $50 billion. The scale is real, the local upside is real, and the utility politics are just warming up.